(26 days)
This document does not contain any predicate devices with K/DEN numbers.
Not Found
No
The summary describes a biofeedback and stimulation device that applies electrical stimulation. There is no mention of AI, ML, image processing, or any data analysis that would suggest the use of such technologies.
Yes
The device is explicitly stated to be used "for therapy in the treatment of urinary incontinence" and for "perineal reeducation and stimulation," indicating a therapeutic purpose.
No
This device is described as an electrical stimulator used for therapy in the treatment of urinary incontinence by applying stimulation to the pelvic floor musculature, not for diagnosis.
No
The device description explicitly states it is an "electrical stimulator" and mentions "Anal/Rectal Probes," which are hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Device Function: The UROSTYM™ Biofeedback and Stimulation Device Anal/Rectal Probes are described as non-implanted electrical stimulators applied to the pelvic floor musculature for therapy. They are used for treatment, not for analyzing samples from the body to diagnose or monitor a condition.
- Intended Use: The intended use is "treating urinary incontinence by way of perineal reeducation and stimulation." This is a therapeutic application, not a diagnostic one.
Therefore, this device falls under the category of a therapeutic medical device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The UROSTYM™ Biofeedback and Stimulation Device Anal/Rectal Probes are used in treating urinary incontinence by way of perineal reeducation and stimulation. This device is a non-implanted electrical stimulator applied the pelvic floor musculature and surrounding structures for therapy in the treatment of urinary incontinence.
Product codes
78 KPI, 85 HIR
Device Description
This device is a non-implanted electrical stimulator applied the pelvic floor musculature and surrounding structures for therapy in the treatment of urinary incontinence. These probes are provided non-sterile for single patient use/disposable.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Anal/Rectal, perineal, pelvic floor musculature
Indicated Patient Age Range
Not Found
Intended User / Care Setting
office use under the direction of a physician or licensed health care professional.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.5320 Nonimplanted electrical continence device.
(a)
Identification. A nonimplanted electrical continence device is a device that consists of a pair of electrodes on a plug or a pessary that are connected by an electrical cable to a battery-powered pulse source. The plug or pessary is inserted into the rectum or into the vagina and used to stimulate the muscles of the pelvic floor to maintain urinary or fecal continence. When necessary, the plug or pessary may be removed by the user. This device excludes an AC-powered nonimplanted electrical continence device and the powered vaginal muscle stimulator for therapeutic use (§ 884.5940).(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS) of the United States of America. The logo features a stylized depiction of a human figure, represented by three curved lines, symbolizing health and well-being. The text "DEPARTMENT OF HEALTH & HUM." is arranged in a circular fashion around the left side of the emblem, while "USA" is positioned on the right side.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NUV 2 9 1999
Mr. Dale Coleman, MS, RAC, CQE Requlatory Affairs Manager Laborie Medical Technologies Corp. 310 Hurricane Lane #2 Williston, VT 05495-2070
Re: K993721
Urostym™ Anal/Rectal Stimulation Probes Dated: November 1, 1999 Received: November 3, 1999 Regulatory Class: II 21 CFR §876.5320/Procode: 78 KPI 21 CFR §884.1425/Procode: 85 HIR
Dear Mr. Coleman:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act indude requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class III (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Fallure to comply with the GMP requlation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
lf you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours.
CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
1
Page / of /
510(k) NUMBER (IF KNOWN) : K99372 I
DEVICE NAME : UROSTYM™ Biofeedback and Stimulation Device Anal/Rectal Probes
INDICATIONS FOR USE:
The UROSTYM™ Biofeedback and Stimulation Device Anal/Rectal Probes are used in treating urinary incontinence by way of perineal reeducation and stimulation. This device is a non-implanted electrical stimulator applied the pelvic floor musculature and surrounding structures for therapy in the treatment of urinary incontinence. These probes are provided non-sterile for single patient use/disposable. The probes are for office use under the direction of a physician or licensed health care professional.
(PLEASE DO NOT WRITE BELOW-THIS LINE- CONTINUE ON ANOTHER
PAGE IF NEEDED.)
| mo 11/29/93 | |
|---|---|
| -- | ------------- |
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescriptive Use (Per 21 CFR 801.109) | OR | Over-The-Counter-use (Optional Format 1-2-96) |
|---|---|---|
| --------------------------------------- | ---- | ----------------------------------------------- |
(Division Sign-Off) Division of Reproductive, Abdominal, ENT. and Radiological Devices 510(k) Number _